Endpoints News 11. Dez. 2025 Weight loss biotech Prolynx gets $70M, snags Amgen's obesity commercial leader as CEO
Endpoints News 11. Dez. 2025 Lilly’s triple agonist posts strongest weight loss data yet, unusual skin side effect also reported
Endpoints News 10. Dez. 2025 Investors buy up stocks in biggest follow-on offering day in biotech history
Endpoints News 10. Dez. 2025 Apple Tree files for bankruptcy as it seeks funds from Russian billionaire backer
Endpoints News 10. Dez. 2025 #SABCS25: Roche’s breast cancer pill cuts post-surgery disease recurrence risk by 30%